News About: Pharm. Industry
Question arises on the existence of ex post facto drug management system
Pharmaceutical business sources say that in parallel with the impending implementation of a new drug price re-evaluation system, the Korea Pharmaceutical Manufacturers Association (KPMA) will call for the government t...
Thorough management of drug prices are emerging in the domestic pharmaceutical industry
Pharmaceutical business sources say that it is necessary for pharmaceutical firms to make thorough management of drug prices in advance, so as to cope with a series of the government's drug-related policies designed t...
Tamiflu getting big popularity
Recently, many experts in European countries have warned the possible outbreak of the most toxic flu which may claim many people's lives.
The National Institute of Health in Korea has been on the alert for flu, say...
Pharmaceutical industry calls for reconsideration of drug-related polices
Pharmaceutical business say that there are mounting discontents over the government's arbitrary drug-related polices designed to sacrifice the domestic pharmaceutical industry through a series of reduction in drug pri...
Formation of pharmaceutical B2B consortium completed
The Korea Pharmaceutical Traders Association (KPTA) has recently said it formed a pharmaceutical B2B (e-trade) consortium in a bid to enhance the competitiveness of the domestic pharmaceutical industry through IT netw...
Pharmaceutical business slowdown forecast to deepen next year
The pharmaceutical business slowdown is expected to further accelerate next year, as the profitability of listed pharmaceutical firms are rapidly aggravated since latter half of this year due to the sluggish growth.
...
President Kim of GSK Korea appointed top position for 6 Asian country control.President Kim Jin-ho of Glaxo Smithkline Korea has been promoted to the top executive position for 6 Asian country management including Thailand, Vietnam, 3 Indo-Chinese countri...
|
Facility investment remarkably declined in listed drug companies.
In contrast to other industries listed in the public stock exchange market where their facility investments substantially increased this year, the listed drug companies spent the least facility investment according to...
Domestic markets for antidepressants and antidiabetics being overheated
Business sources say that the domestic antidepressants and antidiabetics market will be overheated in parallel with the expected launchings of new products on this December or next January.
1) Antidepressant market...
Concerns over possible trade friction are mounting
With the landslide victory of the Republican Party in the US off-year election, pharmaceutical sources are concerned that the presence of the US-based multinational firms will be further heightened in the domestic pha...
